Antibacterial activity of extracellular compounds produced by a Pseudomonas strain against methicillin-resistant

Viviane F Cardozo1, Admilton G Oliveira, Erick K Nishio

  • 1Department of Microbiology, Biology Sciences Center, University of Londrina State, Londrina, PR CP 86005-990, Brazil.

Abstract

Insights

Compounds derived from Pseudomonas aeruginosa show antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). These findings suggest potential alternative treatments for MRSA infections.

Area of Science:

  • Microbiology
  • Drug Discovery
  • Biotechnology

Background:

  • Multidrug-resistant bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), pose a significant global health threat.
  • MRSA is a major cause of both hospital-acquired and community-acquired infections.
  • There is an urgent need for novel therapeutic strategies to combat MRSA infections.

Purpose of the Study:

  • To investigate the antibacterial potential of compounds produced by Pseudomonas aeruginosa against MRSA.
  • To identify and characterize active compounds from P. aeruginosa with efficacy against MRSA.

Main Methods:

  • Isolation and characterization of thirty clinical and three standard MRSA strains.
  • Purification of extracellular compounds from P. aeruginosa using vacuum liquid chromatography.
  • Evaluation of antibacterial activity via agar diffusion, determination of minimal inhibitory concentration, growth/viability curves, and scanning electron microscopy.

Main Results:

  • Fractions F3 and F3d from P. aeruginosa demonstrated significant antibacterial activity against MRSA.
  • Phenazine-1-carboxamide and an organohalogen compound were identified, with the latter showing high antibacterial effect.
  • Scanning electron microscopy revealed that the F3d fraction induced morphological damage to the MRSA cell wall.

Conclusions:

  • Pseudomonas aeruginosa-derived compounds, particularly phenazines, exhibit inhibitory effects against MRSA.
  • These findings highlight the potential of P. aeruginosa metabolites as a viable alternative for controlling MRSA infections.
  • Further research into these compounds could lead to new therapeutic agents against resistant bacterial strains.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...